Actionnariat et activité des initiés pour Indaptus Therapeutics, Inc. (INDP): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $3.21 |
| Capitalisation | $364M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-04-08 | Lu Qinglai | |||
| 2026-03-23 | Yao Yun | |||
| 2026-03-23 | SINO LION VENTURES Ltd | |||
| 2026-03-23 | Dai Junyi | |||
| 2026-03-23 | Lazar David E. | S-Sale | 196,800 | |
| 2026-03-23 | Lazar David E. | S-Sale | 700,000 | |
| 2026-02-26 | Jabbour Jerome D | A-Award | 25,000 | $52K |
| 2026-02-26 | Jabbour Jerome D | |||
| 2026-02-26 | McMurdo Matthew Charles | |||
| 2026-02-11 | Meckler Jeffrey A | A-Award | 12,136 | $21K |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $16.4M | $53.4M | $39.2M | $9.3M | $1.6M | $39.1M | $9.6M | $13.4M | $5.8M | $8.5M |
| Placements à Court Terme | $1.9M | $1.8M | $1.3M | $770000 | 0 | 0 | $16.8M | 0 | 0 | 0 |
| Créances | $721000 | $478000 | $2.0M | $3.5M | 0 | $21056 | 0 | 0 | 0 | 0 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $20.7M | $56.3M | $43.6M | $13.7M | $1.7M | $40.4M | $27.2M | $14.0M | $6.6M | $9.3M |
| Immobilisations Corporelles | $4.0M | $8.2M | $12.2M | $3.8M | $1349 | $172888 | $81313 | $173941 | $82175 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $24.7M | $64.5M | $61.5M | $21.3M | $1.8M | $40.6M | $28.1M | $14.9M | $7.3M | $9.3M |
| Dettes Fournisseurs | $1.2M | $1.9M | $2.8M | $3.5M | $155957 | $2.6M | $1.4M | $806004 | $870229 | $544057 |
| Dette à Court Terme | 0 | 0 | 0 | $544000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $1.9M | $5.7M | $7.7M | $8.3M | $2.0M | $4.6M | $3.4M | $2.8M | $3.4M | $6.2M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $2.0M | $5.7M | $8.0M | $9.7M | $2.0M | $4.7M | $3.4M | $2.8M | $3.4M | $6.2M |
| Réserves | -$62.6M | -$98.3M | -$141.8M | -$189.4M | -$8.0M | -$15.7M | -$30.0M | -$45.4M | -$60.4M | -$81.3M |
| Capitaux Propres | $22.7M | $58.8M | $53.5M | $11.5M | -$237701 | $35.9M | $24.6M | $12.1M | $3.9M | $3.2M |
| Dette Totale | 0 | 0 | 0 | $1.3M | 0 | $169327 | $80494 | $175053 | $84164 | 0 |
| Dette Nette | -$18.3M | -$55.2M | -$40.6M | -$8.7M | -$1.6M | -$39.0M | -$26.4M | -$13.2M | -$5.7M | -$8.5M |
| Fonds de Roulement | $18.8M | $50.6M | $35.9M | $5.4M | -$283495 | $35.8M | $23.8M | $11.2M | $3.2M | $3.2M |
Santé financière
| Dette / Capitaux propres | 0.00 |
| Ratio de liquidité | 19.48 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -18.57 |
Rentabilité
| Rentabilité des capitaux propres | -302.75% |
| Rentabilité du capital investi | -129.90% |
| Rentabilité des actifs | -128.66% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: ATXI · AZTR · GTBP · LIPO · NKGN · PBM · PTIX
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de INDP: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions